title: Response to DDAVP stimulation in thirteen patients with Buerger's disease.
authors.affiliation: INSERM U 428, Hôpital Broussais, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Siguret
authors.forename: M
authors.initials: M
authors.lastname: Alhenc-Gelas
authors.forename: M
authors.initials: M
authors.lastname: Aiach
authors.forename: J N
authors.initials: JN
authors.lastname: Fiessinger
authors.forename: P
authors.initials: P
authors.lastname: Gaussem
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D003894:Deamino Arginine Vasopressin; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D013919:Thromboangiitis Obliterans / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000097:blood
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D017395:Plasminogen Activator Inhibitor 1; D010959:Tissue Plasminogen Activator; D003894:Deamino Arginine Vasopressin